Panjaisee S, Peunpatom N, Weerasarn K. Clinical Practice Guidelines for Traumatic Brain Injury (1st edition). Bangkok: Thana Press. 2013:1-2.
Bureau of Policy and Strategy Ministry of Public Health. Public Health Statistics A.D. 2015. (Accessed Dec 26, 2016 at http://bps.moph.go.th/new_bps/sites/default/files/health_ statistic2558.pdf.)
3. Torbic H, Forni AA, Anger KE, et al. Use of antiepileptics for seizure prophylaxis after traumatic brain injury. Am J Health-Syst Pharm 2013; 70: 759-66.
Algattas H, Huang JH. Traumatic brain injury pathophysiology and treatments: early, intermediate, and late phases postinjury. Int J Mol Sci 2014;15:309-41.
The Department of Surgical Education, Orlando Regional Medical Center. Seizure prophylaxis in patients with traumatic brain injury. 2012. (Assessed Dec 26, 2016 at http:// www.surgicalcriticalcare.net/Guidelines/Seizure%20prophylaxis% 20in%20TBI.pdf.)
Brain Trauma Foundation. Guidelines for the management of severe traumatic brain injury 4th edition. 2016:120-9. (Assessed Dec 26, 2016 at https://braintrauma.org/uploads/ 03/12/Guidelines_for_Management_of_Severe_ TBI_4th_Edition.pdf.)
Thompson K, Pohlmann-Eden B, Campbell LA, et al. Pharmacological treatments for preventing epilepsy following traumatic head injury. Cochrane Database Syst Rev 2015;8:1- 83.
Temkin NR, Dikmen SS, Wilensky AJ, et al. A randomized, double-blind study of Phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990;323(8):497-502.
Frend V, Chetty M. Dosing and therapeutic monitoring of phenytoin in young adults after neurotrauma: are current practices relevant? Clin Neuropharmacol 2007;30:362-9.
Zafar SN, Khan AA, Ghauri AA, et al. Phenytoin versus Leviteracetam for seizure prophylaxis after brain injury - a meta-analysis. BMC Neurol 2012;12(30):1-8.
Nau KM, Divertie GD, Valentino AK, et al. Safety and efficacy of Levetiracetam for critically ill patients with seizures. Neurocrit Care 2009;11:34-7.
Inaba K, Menaker J, Branco BC, et al. A prospective multicenter comparison of Levetiracetam versus Phenytoin for early posttraumatic seizure prophylaxis. J Trauma Acute Care Surg 2013; 74(3):766-73.
Gabriel WM, Rowe AS. Long-term comparison of GOS-E scores in patients treated with Phenytoin or Levetiracetam for posttraumatic seizure prophylaxis after traumatic brain injury. Ann Pharmacother 2014;48(11):1440-4.
Pieracci FM, Moore EE, BeauchampK, et al. A cost-minimization analysis of Phenytoin versus Levetiracetam for early seizure pharmacoprophylaxis after traumatic brain injury. J Trauma 2012;72: 276-81.
Cottn BA, Kao LS, Kozar R, et al. Cost-utility analysis of Levetiracetam and Phenytoin for posttraumatic seizure prophylaxis. J Trauma 2011;71:375-9.
Temkin NR, Dikmen SS, Anderson GD, et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg 1999;91(4):593-600.
Glötzner FL, Haubitz I, Miltner F, et al. Seizure prevention using carbamazepine following severe brain injuries. Neurochirurgia 1983;26(3):66-79.
